Hengxu Capital
Shanghai, Shanghaihengxucapital.com
Overview
Hengxu Capital, founded in 2019, is a market-oriented private equity company with a strong industrial background. Its equity investment team focuses on technology, healthcare, and consumer sectors, and other opportunities aligned with China's economic transformation and new quality productive forces. The alternative investment team focuses on merger-and-acquisition opportunities of high-quality assets in the fields of wind power, photovoltaics, energy storage, charging, and other new energy infrastructures.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| 浙江老鹰半导体技术有限公司 | Oct 2025 | Series B Extension | Co-investor |
| Xi'an Eswin Material Technology Co., Ltd. | Dec 2022 | Series C | Co-investor |
| 北京英创汇智科技有限公司 | Aug 2022 | Series B Extension | Lead |
| UroViu Corporation | Jul 2022 | Series A | Lead |
| Nanovision Technology | Nov 2021 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
